Q6Z6M4 AF NFT

Isocitrate lyase

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeicq3ccj2yldaqk5pdc6oeesshxg2wz3tgu6jd5rf4r3rs2ijqii64/metadata.json

IPFS of structure file:

bafybeidouznkom4qguzjdshggiuzaq2ul3xdnit54j2zlxdup46mvstdmu/AF-Q6Z6M4-F1-model_v2.pdb

First NFT owner address (eip-55):

0x1fcE3327393F11CD8ba520910874709681603C79

First NFT owner address (bech32):

genesis1rl8rxfee8ugumza9yzgssarsj6qkq0reqg6k8a

Current NFT ID #5570 owner (web3):

0x1fcE3327393F11CD8ba520910874709681603C79

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
5570
Accession (UniProt):
Q6Z6M4
Name::
Isocitrate lyase
Experimental Method:
Predicted structure
Sequence source:
ORYZA SATIVA SUBSP. JAPONICA

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q6Z6M4 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q6Z6M4|ACEA_ORYSJ Isocitrate lyase OS=Oryza sativa subsp. japonica OX=39947 GN=ICL PE=1 SV=1 MSSPFSVPSLIMEEEGRFEAEVAEVEAWWGTDRFRLTKRPYTARDVALLRGTLRQSYASGDMAKKLWRTLRAHQANGTASRTFGALDPVQVAMMAKHLDTVYVSGWQCSSTHTSTNEPGPDLADYPYDTVPNKVEHLFFAQLYHDRKQREARMSMSRAERAHEPYVDYLKPIIADGDTGFGGATATVKLCKLFVERGAAGVHLEDQSSVTKKCGHMAGKVLVAVSEHVNRLVAARLQFDIMGVETVLVARTDAVAATLIQTNVDARDHQFILGATNPRLRNRSLAAVLSDAMSAGKNGRELQAIEDEWLATAQLKTFSDCVRDAIASLNATDADKQRKLQEWSAATSHDKCVPLEQARDIAAGLGVTSLFWDWDLPRTREGFYRFRGSVAAAVVRGRAFAPHADVLWMETSSPNIAECTAFAEGVRAASPGAMLAYNLSPSFNWDASGMTDADMSEFIPRVARLGYVWQFITLAGFHADALVTDTFARDFARRGMLAYVERIQREERSNGVETLQHQKWSGANFYDRVLKTVQGGISSTAAMGKGVTEEQFKGSWTGPGSESSSHVLAKSRM

MOLNFT AF v1_w

NFT data

MOLNFT Q6Z6M4 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience